The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases. [PDF]
Strauss MH +3 more
europepmc +1 more source
Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fraction. [PDF]
Humphreys ABC +9 more
europepmc +1 more source
Hospitalisations Related to the Combination of ACE Inhibitors and/or Angiotensin Receptor Blockers with Diuretics and NSAIDs: A Post Hoc Analysis on the Risks Associated with Triple Whammy. [PDF]
Mattioli I +7 more
europepmc +1 more source
Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET<sup>®</sup> in Japan. [PDF]
Kinoshita Y +11 more
europepmc +1 more source
Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping. [PDF]
Duvvuri VR +12 more
europepmc +1 more source
The impact of dose and discontinuation timing of preoperative ACE inhibitors on survival outcomes in cardiac surgery: A MIMIC-IV database analysis. [PDF]
Zou X +6 more
europepmc +1 more source
ACE Inhibitors and ARBs in Chronic Kidney Disease: A Systematic Review of Randomized Controlled Trials on Albuminuria Reduction, eGFR Decline, and Safety. [PDF]
Avula A +11 more
europepmc +1 more source
The use of HCT and/or ACE inhibitors significantly increases the risk of non-melanotic skin cancer in the periocular region. [PDF]
Mehlan J +6 more
europepmc +1 more source
Investigating potent cardioprotective compounds as ACE inhibitors in Saraca asoca. [PDF]
Prasad S, Younis K, Yousuf O.
europepmc +1 more source
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19. [PDF]
Tetlow S +17 more
europepmc +1 more source

